跳至主要内容
临床试验/NL-OMON34621
NL-OMON34621尚未招募不适用

Drug eluting balloon for in-stent restenosis. Multi-center, randomized trial to study the effect of the SeQuent Please drug-eluting balloon versus the Xience Prime drug-eluting stent for the treatment of in-stent restenosis - Drug eluting balloon for in-stent restenosis

Academisch Medisch Centrum0 个研究点目标入组 270 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
270

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Restenosis of initially stented coronary artery
  • Restenosis of any type of stent; all drug-eluting stents or bare metal stents
  • Restenosis must be present > 50% in-stent and < 5 mm out of the stent
  • Amendable to PCI treatment with either the SeQuent Please DEB or the Xience Prime DES

排除标准

  • The impossibility to arrange a follow-up coronary angiography at 6 months (± 1 month) after baseline procedure
  • Life expectancy less than one year
  • In-stent re-restenosis already treated with a second stent
  • Requirement for PCI in the same vessel or expected in the next 6 months

研究者

相似试验